Cited by 230Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on BehaviorSchizophrenia research and treatment

The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.

A Pilot Controlled Clinical Trial of ABT-418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder

Wilens, Timothy E., Biederman, Joseph, Spencer, Thomas J., Bostic, Jeff, Prince, Jefferson, Monuteaux, Michael C., Soriano, Jennifer, Fine, Catherine, Abrams, Annah, Rater, Michael, Polisner, David·1999·American Journal of Psychiatry

DOI 10.1176/ajp.156.12.1931

Open this paper in CoChat — free account

Abstract

OBJECTIVE: Despite the increasing recognition of attention deficit hyperactivity disorder (ADHD) in adults, there is a paucity of controlled pharmacological trials. Recent reports have suggested the potential usefulness of cholinergic agents for ADHD. To this end, the authors completed a controlled study of ABT-418, a novel cholinergic activating agent, for the treatment of adults with ADHD. METHOD: This was a double-blind, placebo-controlled, randomized, crossover trial that compared a transdermal patch of ABT-418 (75 mg/day) to placebo in adults who met DSM-IV criteria for ADHD. There were two 3-week treatment periods separated by 1 week of washout. RESULTS: Of the 32 subjects enrolled in the study (88% were men; mean age = 40 years, SD = 9), 29 completed the study. At the endpoint of each active arm (last observation carried forward), a significantly higher proportion of subjects was considered improved while receiving ABT-418 than while receiving placebo (40% versus 13%). Similarly, at endpoint there was a significantly greater reduction in ADHD symptom checklist scores (28% versus 15%). Symptoms reflective of attention, and subjects with less severe ADHD, responded more robustly to ABT-418. Treatment with ABT-418 was relatively well tolerated; dizziness and nausea were the most frequently reported adverse effects. CONCLUSIONS: The results of this investigation indicate that ABT-418, a nicotinic analog, may be a potentially useful agent for the treatment of ADHD.

Integrity signals

Registry

Crossref · 10.1176/ajp.156.12.1931

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

An inventory for measuring depression
BECK, A. T. (1961) · Archives of General Psychiatry · doi:10.1001/archpsyc.1961.01710120031004 · Cited by 38,032
A rating scale for depression
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The assessment of anxiety states by rating
HAMILTON, M. (1959) · British Journal of Medical Psychology · doi:10.1111/j.2044-8341.1959.tb00467.x · Cited by 11,455
Four Factor Index of Social Status
Paschou, R. (1975) · Cited by 6,989
Attention Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment
Barkley, R. A., & Poillion, M. J. (1994) · Behavioral Disorders · doi:10.1177/019874299401900205 · Cited by 4,635
The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder [published erratum appears in Am J Psychiatry 1993 Aug;150(8):1280]
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.6.885 · Cited by 1,421
Adult Outcome of Hyperactive Boys: Educational Achievement, Occupational Rank, and Psychiatric Status
Mannuzza, S. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820190067007 · Cited by 1,368
Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder
(1993) · American Journal of Psychiatry · doi:10.1176/ajp.150.12.1792 · Cited by 950 · cited 1×
“Characterized by high degrees of symptoms of inattentiveness (7), adults with ADHD have been documented in controlled studies to have more psychopathology, substance abuse, occupational, academic, and relationship difficulties than adults without ADHD (3, 4, 8, 9).”
BackgroundSelf-citation
Some Conceptual and Statistical Issues in Analysis of Longitudinal Psychiatric Data
Gibbons, R. D. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820210073009 · Cited by 719
Developmental change in attention-deficit hyperactivity disorder in boys: A four-year longitudinal study
Hart, E. L., Lahey, B. B., Loeber, R., Applegate, B., & Frick, P. J. (1995) · Journal of Abnormal Child Psychology · doi:10.1007/bf01447474 · Cited by 590

Flagged first, then by citations

Show all 50 references

Research works printed but not linked: 3

Arneric SP, Sullivan JP, Briggs CA, Donnelly-Roberts D, Anderson DJ, Raszkiewicz JL, Hughes ML, Cadman ED, Adams P, Garvey DS, Wasicak J, Williams M: (S)-3-Methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities, I: in vitro characterization. J Pharmacol Exp Ther 1994; 270:310–318
NIMH: Clinical Global Impressions (CGI) scale. Psychopharmacol Bull 1985; 21:839–843
Stein MA, Sandoval R, Szumowski E, Roizen N, Reinecke MA, Blondis TA, Klein Z: Psychometric characteristics of the Wender Utah Rating Scale: reliability and factor structure for men and women. Psychopharmacol Bull 1995; 31:423–431

Sorted by citations

Items 101–200 of 229

Smoking Withdrawal Symptoms Are More Severe Among Smokers With ADHD and Independent of ADHD Symptom Change: Results From a 12-Day Contingency-Managed Abstinence Trial
McClernon, F. J., Voorhees, E. E. V., English, J. S., Hallyburton, M., Holdaway, A., & Kollins, S. H. (2011) · Nicotine & Tobacco Research · doi:10.1093/ntr/ntr073 · Cited by 53
Efficacy and safety of the novel α4β2 neuronal nicotinic receptor partial agonist ABT-089 in adults with attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled crossover study
Apostol, G., Abi‐Saab, W., Kratochvil, C. J., Adler, L. A., Robieson, W., Gault, L. M., Pritchett, Y., Feifel, D., Collins, M. A., & Saltarelli, M. D. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2393-2 · Cited by 53
Nicotinic α4β2 Cholinergic Receptor Influences on Dorsolateral Prefrontal Cortical Neuronal Firing during a Working Memory Task
Sun, Y., Yang, Y., Galvin, V. C., Yang, S., Arnsten, A. F. T., & Wang, M. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0364-17.2017 · Cited by 55
Involvement of dopaminergic and cholinergic systems in social isolation-induced deficits in social affiliation and conditional fear memory in mice
Okada, R., Fujiwara, H., Mizuki, D., Araki, R., Yabe, T., & Matsumoto, K. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.064 · Cited by 54
Pharmacotherapy of ADHD in Adults
Wilens, T. E. (2008) · CNS Spectrums · doi:10.1017/s1092852900002960 · Cited by 50
Self-citation
Attention-deficit/hyperactivity disorder: A plausible mouse model?
Granon, S., & Changeux, J. (2006) · Acta Paediatrica · doi:10.1080/08035250600719747 · Cited by 53
Manipulation of nicotinic acetylcholine receptors differentially affects behavioral inhibition in human subjects with and without disordered baseline impulsivity
Potter, A., Bucci, D. J., & NEWHOUSE, P. A. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2476-0 · Cited by 47
Atomoxetine Treatment for Cocaine Abuse and Adult Attention-Deficit Hyperactivity Disorder (ADHD): A Preliminary Open Trial
Levin, F., Mariani, J., Secora, A., Brooks, D. J., Cheng, W., Bisaga, A., Nunes, E., Aharonovich, E., Raby, W. N., & Hennessy, G. (2009) · Journal of dual diagnosis · doi:10.1080/15504260802628767 · Cited by 47
Posttraumatic stress disorder and smoking relapse: A theoretical model
Cook, J. W., McFall, M., Calhoun, P. S., & Beckham, J. C. (2007) · Journal of Traumatic Stress · doi:10.1002/jts.20275 · Cited by 44
Attention Deficit/Hyperactivity Disorder in Adults
Moss, S. B., Nair, R. J., Vallarino, A., & Wang, S. (2007) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2007.05.005 · Cited by 45
Cigarette smoking and ADHD: An examination of prognostically relevant smoking behaviors among adolescents and young adults.
Rhodes, J. D., Pelham, W. E., Gnagy, E. M., Shiffman, S. M., Derefinko, K. J., & Molina, B. S. G. (2016) · Psychology of Addictive Behaviors · doi:10.1037/adb0000188 · Cited by 45
Does parental ADHD bias maternal reports of ADHD symptoms in children?
Faraone, S. V., Monuteaux, M. C., Biederman, J., Cohan, S. L., & Mick, E. O. (2003) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.71.1.168 · Cited by 42
Self-citation
Ion Channel Mutations in Neuronal Diseases: A Genetics Perspective
Steinlein, O. K. (2012) · Chemical Reviews · doi:10.1021/cr300044d · Cited by 43
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
Schweitzer, J. B., Cummins, T. K., & Kant, C. (2001) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70339-4 · Cited by 44
Prenatal nicotine exposure is associated with an increase in [125I]epibatidine binding in discrete cortical regions in rats
Tizabi, Y., & Perry, D. C. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(00)00379-8 · Cited by 43
Serotoninergics attenuate hyperlocomotor activity in rats. Potential new therapeutic strategy for hyperactivity
Brus, R., Nowak, P. G., Szkilnik, R., Mikolajun, U., & Kostrzewa, R. M. (2004) · Neurotoxicity Research · doi:10.1007/bf03033442 · Cited by 41
Nicotinic ligands as multifunctional agents for the treatment of neuropsychiatric disorders
Terry, A. V., Callahan, P. M., & Hernandez, C. M. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.07.027 · Cited by 40
Attention as a target of intoxication:
Bushnell, P. J., Levin, E. D., Marrocco, R. T., Sarter, M. F., Strupp, B. J., & Warburton, D. M. (2000) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(00)00077-5 · Cited by 40
Methylphenidate increases cigarette smoking in participants with ADHD
Vansickel, A., Stoops, W. W., Glaser, P., Poole, M. M., & Rush, C. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2328-y · Cited by 41
An Open Trial of Adjunctive Donepezil in Attention-Deficit/Hyperactivity Disorder
Wilens, T. E., Waxmonsky, J. G., Scott, M., Swezey, A., Kwon, A., Spencer, T. J., & Biederman, J. (2005) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2005.15.947 · Cited by 37
Self-citation
A Double-blind Comparison of Galantamine Hydrogen Bromide and Placebo in Adults With Attention-Deficit/Hyperactivity Disorder: A Pilot Study
Biederman, J., Mick, E., Faraone, S., Hammerness, P. G., Surman, C. B. H., Harpold, T., Dougherty, M., Aleardi, M., & Spencer, T. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000204139.20417.8a · Cited by 26
Self-citation
AZD3480, a Novel Nicotinic Receptor Agonist, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults
Potter, A., Dunbar, G. C., Mazzulla, E. C., Hosford, D. A., & NEWHOUSE, P. A. (2013) · Biological Psychiatry · doi:10.1016/j.biopsych.2013.06.002 · Cited by 36
Practice Parameter for the Use of Stimulant Medications in the Treatment of Children, Adolescents, and Adults
Greenhill, L. L., Pliszka, S. R., Dulcan, M. K., Bernet, W., Arnold, V. K., Beitchman, J. H., Benson, R. S., Bukstein, O., Kinlan, J., McClellan, J., et al. (2004) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.2.4.642 · Cited by 36
Autism - A Neurodevelopmental Journey from Genes to Behaviour
Eapen, V. (2011) · InTech eBooks · doi:10.5772/974 · Cited by 36
Nicotinic-antipsychotic drug interactions and cognitive function
Levin, E. D., & Rezvani, A. H. (2006) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-7772-4_10 · Cited by 36
Safety and Efficacy of ABT-089 in Pediatric Attention-Deficit/Hyperactivity Disorder: Results from Two Randomized Placebo-Controlled Clinical Trials
Wilens, T. E., Gault, L. M., Childress, A. C., Kratochvil, C. J., Bensman, L., Hall, C. M., Olson, E., Robieson, W., Garimella, T. S., Abi‐Saab, W., et al. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.10.001 · Cited by 34
Self-citation
Donepezil in the Treatment of ADHD-Like Symptoms in Youths With Pervasive Developmental Disorder
Doyle, R., Frazier, J. A., Spencer, T. J., GELLER, D. A., Biederman, J., & Wilens, T. E. (2006) · Journal of Attention Disorders · doi:10.1177/1087054705284091 · Cited by 33
Self-citation
Unravelling the mechanism of action of NS9283 , a positive allosteric modulator of ( α 4)3( β 2)2nicotinic ACh receptors
Grupe, M., Jensen, A. A., Ahring, P. K., Christensen, J., & Grunnet, M. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12095 · Cited by 32
Association study of the nicotinic acetylcholine receptor α4 subunit gene, CHRNA4, in attention‐deficit hyperactivity disorder
Lee, J., Laurin, N., Crosbie, J., Ickowicz, A., Pathare, T., MALONE, M. A., Kennedy, J. L., Tannock, R., Schachar, R. J., & Barr, C. L. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00325.x · Cited by 31
BIOPHYSICAL MODELING OF TONIC CORTICAL ELECTRICAL ACTIVITY IN ATTENTION DEFICIT HYPERACTIVITY DISORDER
ROWE, D. L., Robinson, P. A., Lazzaro, I., Powles, R. C., Gordon, E., & Williams, L. M. (2005) · International Journal of Neuroscience · doi:10.1080/00207450590934499 · Cited by 34
Effects of acute ultra‐low dose mecamylamine on cognition in adult attention‐deficit/hyperactivity disorder (ADHD)
Potter, A., Ryan, K. K., & NEWHOUSE, P. A. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1026 · Cited by 30
Attention-deficit/hyperactivity disorder in children and adolescents: interventions for a complex costly clinical conundrum.
Greydanus, D., Pratt, H., Sloane, M. A., & Rappley, M. (2003) · The Pediatric clinics of North America · doi:10.1016/s0031-3955(03)00081-6 · Cited by 23
Evidence-based long-term treatment of bipolar II disorder.
Suppes, T. M., & Dennehy, E. B. (2002) · PubMed · Cited by 29
Effects of chronic sazetidine-A, a selective α4β2 neuronal nicotinic acetylcholine receptors desensitizing agent on pharmacologically-induced impaired attention in rats
Rezvani, A. H., Cauley, M. C., Xiao, Y., Kellar, K. J., & Levin, E. D. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2895-6 · Cited by 28
Orthosteric and Allosteric Ligands of Nicotinic Acetylcholine Receptors for Smoking Cessation
Mohamed, T. S., Jayakar, S. S., & Hamouda, A. K. (2015) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2015.00071 · Cited by 27
A randomized controlled trial of a novel mixed monoamine reuptake inhibitor in adults with ADHD
Wilens, T. E., Klint, T., Adler, L. A., West, S. A., Wesnes, K. A., Graff, O. X., & Mikkelsen, B. O. (2008) · Behavioral and Brain Functions · doi:10.1186/1744-9081-4-24 · Cited by 27
Self-citation
Acute effects of mecamylamine and varenicline on cognitive performance in non-smokers with and without schizophrenia
Roh, S., Hoeppner, S. S., Schoenfeld, D., Fullerton, C. A., Stoeckel, L. E., & Evins, A. E. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3286-3 · Cited by 28
Startle response during smoking and 24 h after withdrawal predicts successful smoking cessation
Postma, P., Kumari, V., Sharma, T., Hines, M., & Gray, J. A. (2001) · Psychopharmacology · doi:10.1007/s002130100829 · Cited by 26
A randomized, double-blind, placebo-controlled crossover study of α4β2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder
Jučaitė, A., Öhd, J., Potter, A., Jaeger, J., Karlsson, P., Hannesdóttir, K., Boström, E., NEWHOUSE, P. A., & Paulsson, B. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3116-7 · Cited by 25
Literature Review: Beyond Methylphenidate
Wood, J. G., Crager, J. L., Delap, C. M., & Heiskell, K. D. (2007) · Journal of Attention Disorders · doi:10.1177/1087054707305968 · Cited by 23
Differential effects of cholinergic and noradrenergic neuromodulation on spontaneous cortical network dynamics
Schmidt, S. L., Chew, E. Y., Bennett, D., Hammad, M. A., & Frӧhlich, F. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.045 · Cited by 24
Effects of AZD3480, a neuronal nicotinic acetylcholine receptor agonist, and donepezil on dizocilpine-induced attentional impairment in rats
Rezvani, A. H., Cauley, M. C., Johnson, E. C., Gatto, G. J., & Levin, E. D. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2712-2 · Cited by 21
The familial association between cigarette smoking and ADHD: A study of clinically referred girls with and without ADHD, and their families
Monuteaux, M. C., Faraone, S. V., Hammerness, P. G., Wilens, T. E., Fraire, M. G., & Biederman, J. (2008) · Nicotine & Tobacco Research · doi:10.1080/14622200802326137 · Cited by 21
Self-citation
The α4β2 nicotinic acetylcholine receptor modulates autism-like behavioral and motor abnormalities in pentylenetetrazol-kindled mice
Takechi, K., Suemaru, K., Kiyoi, T., Tanaka, A., & Araki, H. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.02.021 · Cited by 21
Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder
Nasser, A. F., Kosheleff, A. R., Hull, J. T., Liranso, T., Qin, P., Busse, G. D., O’Neal, W., D, M. F. M., Faraone, S. V., & Rubin, J. S. (2021) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2020.0148 · Cited by 22
Cognition as a therapeutic target in late-life depression: Potential for nicotinic therapeutics
Zurkovsky, L., Taylor, W. D., & NEWHOUSE, P. A. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.032 · Cited by 20
Pharmacokinetics and Safety Profile of Ispronicline (TC‐1734), a New Brain Nicotinic Receptor Partial Agonist, in Young Healthy Male Volunteers
Dunbar, G., Demazières, A., Monreal, A., Cisterni, C., Metzger, D., Kuchibhatla, R., & Luthringer, R. (2006) · The Journal of Clinical Pharmacology · doi:10.1177/0091270006288730 · Cited by 20
Dissociation of nicotinic α7 and α4/β2 sub-receptor agonists for enhancing learning and attentional filtering in nonhuman primates
Azimi, M., Oemisch, M., & Womelsdorf, T. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05430-w · Cited by 19
Role of conduct problems in the relation between Attention-Deficit Hyperactivity disorder, substance use, and gaming.
Schoenmacker, G., Groenman, A., Sokolova, E., Oosterlaan, J., Rommelse, N., Roeyers, H., Oades, R., Faraone, S., Franke, B., Heskes, T., et al. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.06.003 · Cited by 14
Attention
Callahan, P. M., & Terry, A. V. (2015) · Handbook of experimental pharmacology · doi:10.1007/978-3-319-16522-6_5 · Cited by 19
The KCNH3 inhibitor ASP2905 shows potential in the treatment of attention deficit/hyperactivity disorder
Takahashi, S., Ohmiya, M., Honda, S., & Ni, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207750 · Cited by 18
NAChR α4β2 Subtype and their Relation with Nicotine Addiction, Cognition, Depression and Hyperactivity Disorder
Laikowski, M. M., Reisdorfer, F., & Moura, S. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666180410105135 · Cited by 17
New developments in psychopharmacology of attention deficit hyperactivity disorder
Pliszka, S. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.10.1797 · Cited by 13
Decreased α4β2 nicotinic receptor number in the absence of mRNA changes suggest post-transcriptional regulation in the spontaneously hypertensive rat model of ADHD
Wigestrand, M. B., Mineur, Y., Heath, C. J., Fonnum, F., Picciotto, M. R., & Walaas, S. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07415.x · Cited by 18
Decreasing nicotinic receptor activity and the spatial learning impairment caused by the NMDA glutamate antagonist dizocilpine in rats
Burke, D. A., Heshmati, P., Kholdebarin, E., & Levin, E. D. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.030 · Cited by 16
A combined α7 nicotinic acetylcholine receptor agonist and monoamine reuptake inhibitor, NS9775, represents a novel profile with potential benefits in emotional and cognitive disturbances
Andreasen, J. T., Redrobe, J. P., Nielsen, E. Ø., Christensen, J. K., Olsen, G. M., & Peters, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.060 · Cited by 15
Clinical Aspects of Nicotinic Agents: Therapeutic Applications in Central Nervous System Disorders
NEWHOUSE, P. A., & Kelton, M. (2000) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-57079-7_26 · Cited by 14
Molecular Genetics of ADHD
Misener, V. L., & Barr, C. L. (2008) · Nucleic acids and molecular biology · doi:10.1007/978-3-540-85383-1_4 · Cited by 13
Fortschritte in der Pharmakotherapie
Wilens, T. E., & Dittmann, R. (2003) · Springer eBooks · doi:10.1007/978-3-642-92473-6_7 · Cited by 13
Self-citation
The enhancement of contextual fear conditioning by ABT-418
Kenney, J. W., Wilkinson, D. S., & Gould, T. J. (2010) · Behavioural Pharmacology · doi:10.1097/fbp.0b013e32833a5b9d · Cited by 12
Effects of lisdexamfetamine alone and in combination with s‐citalopram on acetylcholine and histamine efflux in the rat pre‐frontal cortex and ventral hippocampus
Hutson, P. H., Heins, M., & Folgering, J. H. A. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13157 · Cited by 11
Nicotinic Acetylcholine Receptor Alterations in Autism Spectrum Disorders – Biomarkers and Therapeutic Targets
Anand, R., Stephanie, A., Ponath, G. D., Jordan, I., Nasir, M. I., & Susan, B. (2011) · InTech eBooks · doi:10.5772/20752 · Cited by 11
Chromaproline and Chromaperidine, nicotine agonists, and Donepezil, cholinesterase inhibitor, enhance performance of memory tasks in ovariectomized rats
Luine, V. N., Mohan, G., Tu, Z., & Efange, S. M. N. (2002) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(02)00988-7 · Cited by 13
Current nonstimulant medications for adults with attention-deficit/hyperactivity disorder
Brancati, G. E., Magnesa, A., Acierno, D., Carli, M., Rosa, U. D., Froli, A., Gemignani, S., Ventura, L., Weiss, F., & Perugi, G. (2024) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2024.2370346 · Cited by 16
Pharmacotherapy of ADHD in adults
Prince, J. B., Morrison, N. R., & Wilens, T. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781139035491.023 · Cited by 11
Self-citation
Diagnostic and Treatment Issues in Comorbid Substance Abuse and Adult Attention-Deficit Hyperactivity Disorder
Levin, F., & Evans, S. (2001) · Psychiatric Annals · doi:10.3928/0048-5713-20010501-08 · Cited by 14
A comparative study of the effects of ABT-418 and methylphenidate on spatial memory in an animal model of ADHD
Guo, T., Yang, C., Guo, L., & Liu, K. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.08.068 · Cited by 10
Present and future pharmacotherapeutic options for adult attention deficit/hyperactivity disorder
Horrigan, J. P. (2001) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2.4.573 · Cited by 11
Applications of pharmacogenetics in children with attention-deficit/hyperactivity disorder
Lévy, F. (2014) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s52844 · Cited by 10
Current issues in child and adolescent psychopharmacology. Part 1: Attention-deficit hyperactivity and affective disorders
Coghill, D. (2003) · Advances in Psychiatric Treatment · doi:10.1192/apt.9.2.86 · Cited by 10
Pozanicline for the treatment of attention-deficit/hyperactivity disorder
Childress, A., & Sallee, F. (2014) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2014.956078 · Cited by 10
Attention deficit hyperactivity disorder. Epidemiologic, pathophysiologic, diagnostic and treatment perspectives
Al-Ghamdy, Y. S., & Qureshi, N. A. (2001) · Saudi Medical Journal · doi:10.15537/1658-3175.1472 · Cited by 10
Neurobiology of nAChRs and cognition: A mini review of Dr. Jerry J. Buccafusco's contributions over a 25 year career
Terry, A. V., & Decker, M. W. (2011) · Biochemical Pharmacology · doi:10.1016/j.bcp.2011.06.010 · Cited by 7
Varenicline in Autistic Disorder: Hypothesis and Case Report of Single-Patient Crossover
Arnold, L. E., Anand, R., & Aman, M. G. (2013) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2012.0025 · Cited by 7
The potential of neuronal nicotinic acetylcholine receptor agonists for treating CNS conditions
Decker, M. W., Gopalakrishnan, M., & Meyer, M. D. (2008) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.9.1027 · Cited by 7
Special issue on the psychopharmacology of prepulse inhibition: basic and clinical studies
Koch, M., & Robbins, T. W. (2001) · Psychopharmacology · doi:10.1007/s002130100826 · Cited by 7
Trouble déficitaire de l'attention avec hyperactivité chez l'adulte
Grosse, E.-M., Fonséca, D. D., Fakra, É., Poinso, F., & Samuelian, J. (2007) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2007.04.001 · Cited by 5
Advances in alternative pharmacotherapy of ADHD.
Pityaratstian, N. (2005) · PubMed · Cited by 6
Tobacco smoking and mental illness: important considerations
Feeney, S., & Hallahan, B. P. (2011) · Irish Journal of Psychological Medicine · doi:10.1017/s0790966700012027 · Cited by 5
Model of Attention Deficit Hyperactivity Disorder: Five‐Trial, Repeated Acquisition Inhibitory Avoidance in Spontaneously Hypertensive Rat Pups
Fox, G. B. (2004) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0537s26 · Cited by 4
Non-Stimulant Trials of Adult ADHD
Adler, L. A. (2007) · CNS Spectrums · doi:10.1017/s109285290002602x · Cited by 4
Towards a Biological Understanding of ADHD and the Discovery of Novel Therapeutic Approaches
Tannock, R., Campbell, B., Seymour, P. A., Ouellet, D., Soares, H. D., Wang, P., & Chappell, P. B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-12-373861-5.00010-2 · Cited by 4
Attention Deficit Hyperactivity Disorder: Pathophysiology and Design of New Treatments
Glase, S. A., & Dooley, D. J. (2004) · Annual reports in medicinal chemistry · doi:10.1016/s0065-7743(04)39001-9 · Cited by 3
New Frontiers
Silk, T. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814180-9.00013-2 · Cited by 4
Implication du système cholinergique dans l'altération de la mémoire de travail au cours du vieillissement chez la souris : approche comportementale, pharmacologique et neurofonctionnelle
Vandesquille, M. (2011) · theses.fr (ABES) · doi:10.70675/ad96bd3dz8a44z499czbeacz7a1e24572e30 · Cited by 2
Evaluation of adult attention deficit hyperactivity disorder in smokers and Maras powder users
Keten, H., Onay, H., Ersoy, O., Işık, O., Gençoğlan, S., Ucer, H., & Çelik, M. (2015) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1018320 · Cited by 2
Neurobehavioral Comorbidities in Pentylenetetrazol-kindled Mice and Role of the α4β2 Nicotinic Acetylcholine Receptor
Takechi, K. (2019) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.19-00159 · Cited by 2
Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder across the Life Span
Prince, J. B., Spencer, T. J., Wilens, T. E., & Biederman, J. (2008) · Elsevier eBooks · doi:10.1016/b978-0-323-04743-2.50051-2 · Cited by 2
Self-citation
Neuropsychopharmacogenetics: 'stimulating' rationale therapy in attention-deficit/hyperactivity disorder (ADHD): pharmacogenetics of psychostimulants in ADHD
Masellis, M., Basile, V. S., & Kennedy, J. L. (2006) · Springer eBooks · doi:10.1007/0-387-34577-2_9 · Cited by 2
Non-stimulant Drug Treatments for Adults with ADHD
Coghill, D. (2013) · Humana Press eBooks · doi:10.1007/978-1-62703-248-3_6 · Cited by 1
Aufmerksamkeitsdefizit-/Hyperaktivitätsstörung ADHS) im Erwachsenenalter
Alm, B., & Sobanski, E. (2008) · Springer eBooks · doi:10.1007/978-3-540-33129-2_64 · Cited by 2
Perspectives of Alzheimer's disease treatments
Davis, J. B., Bountra, C., & Richardson, J. C. (2008) · Handbook of clinical neurology · doi:10.1016/s0072-9752(07)01226-2 · Cited by 2
TDAH y su comorbilidad adictiva
y Machorro, M. S., Cruz, V. M. G., & Salgado, L. D. B. (2005) · Cited by 2
Nicotinic Acetylcholine Receptor Modulators
Mazurov, A. A., & Yohannes, D. (2014) · Topics in medicinal chemistry · doi:10.1007/7355_2014_56 · Cited by 1
ADHS im Erwachsenenalter - Leitlinien auf der Basis eines Expertenkonsensus mit Unterstützung der DGPPN
der Leitlinie, I. A., & Dgppn, M. (2003) · Cited by 1
Cognitive Functions, Attention- Defi cit Hyperactivity Disorders, and Alzheimer's Disease
Passani, M. B., Blandina, P., Browman, K. E., & Fox, G. B. (2008) · CRC Press eBooks · doi:10.1201/9781420053937.secc · Cited by 1
Chapter 19. Pharmacotherapy Of Adhd And Comorbidities
Prince, J. B., & Wilens, T. E. (2008) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615377367.lg19 · Cited by 1
Self-citation
An Analysis of the Interaction of Methylphenidate and Nicotine in Adolescent Rats: Effects on BDNF
Freeman, E. D. (2015) · Digital Commons - East Tennessee State University (East Tennessee State University) · Cited by 1
TDAH en adultos factores genéticos, evaluación y tratamiento farmacológico
Ramos‐Quiroga, J. A. (2009) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Expression of b-Secretase mRNA in the Brain of Rats with Immunohistochemical Destruction of Basal Forebrain Cholinergic System
Lushchekina, E. A., Bigl, M., Apelt, J., Lange‐Dohna, C., Roßner, S., & Schliebs, R. (2002) · Bulletin of Experimental Biology and Medicine · doi:10.1023/a:1021564231603 · Cited by 1

Authors: Wilens, T. E., Biederman, J., Spencer, T. J., Bostic, J., Prince, J., Monuteaux, M. C., Soriano, J., Fine, C., Abrams, A., Rater, M., & Polisner, D.
Affiliations: Harvard University (US)
ORCID: Wilens, Timothy E.
Biederman, Joseph
Bostic, Jeff
Abrams, Annah
Venue: American Journal of Psychiatry
Publisher: American Psychiatric Association Publishing
Published: 1999-12-01
Volume: 156
Issue: 12
Pages: 1931-1937
ISSN: 0002-953X (ISSN-L)
1535-7228
DOI: 10.1176/ajp.156.12.1931
OpenAlex: W2149138665
Cited by: 230
References: 50
Citations by year: 2026: 2 · 2025: 2 · 2024: 1 · 2021: 2 · 2019: 3 · 2018: 5 · 2017: 2 · 2016: 3 · 2015: 8 · 2014: 10 · 2013: 15 · 2012: 10
FWCI: 8.80
Type: journal article
Language: en
Open access: closed
Locations: American Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5k20mh001175-02)
National Institute of Mental Health (MH-01175)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Keywords: ABT-418, attention deficit hyperactivity disorder, adult ADHD, cholinergic agonists, nicotinic agonists, transdermal patch, pharmacotherapy, ADHD symptom improvement, treatment tolerability
MeSH terms: Administration, Cutaneous, Adult, Age Factors, Attention Deficit Disorder with Hyperactivity, Dizziness, Double-Blind Method, Female, Humans, Isoxazoles, Male, Nausea, Pilot Projects, Pyrrolidines, Anti-Anxiety Agents, Treatment Outcome, Cross-Over Studies, Cholinergic Agonists

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

A Pilot Controlled Clinical Trial of ABT-418, a Cholinergic Agonist, in the Treatment of Adults With Attention Deficit Hyperactivity Disorder

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks